EDIT:NASDAQ
Editas Medicine Inc
2,94Â US$
arrow_downward
-0,17%(-0,0050) 1K
29-okt, 12:05:22 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEDIT tikeri uchun statistika yaratilmoqda...
Ochish
2,94Â US$
Yuqori
2,98Â US$
Past
2,89Â US$
Bozor kapitali
452,29Â mln
Oʻrtacha hajm
2,98Â mln
Hajmi
1,89Â mln
52 haftalik eng yuqori
3,94Â US$
52 haftalik eng past
1,66Â US$
Aksiya boʻyicha daromad
-0,74Â US$
Beta
2,00
Muomaladagi aksiyalar
153,58Â mln
Xodimlar soni
87
Ochish
2,94Â US$
Yuqori
2,98Â US$
Past
2,89Â US$
Bozor kapitali
452,29Â mln
Oʻrtacha hajm
2,98Â mln
Hajmi
1,89Â mln
52 haftalik eng yuqori
3,94Â US$
52 haftalik eng past
1,66Â US$
Aksiya boʻyicha daromad
-0,74Â US$
Beta
2,00
Muomaladagi aksiyalar
153,58Â mln
Xodimlar soni
87
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Quartz
·
39 daqiqa oldin
Intercontinental Exchange profit rises, beats Q3 2026 estimates
MobiHealthNews
·
17 daqiqa oldin
Anthropic files for IPO, plans Nasdaq listing under ANT
CNBC
·
9 daqiqa oldin
GM is shifting gears to the Nasdaq, trying to draft behind Walmart’s lead
Bloomberg.com
·
16 soat oldin
Watch Nasdaq 100 Falls as AI Trade Shows New Cracks
Profil
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Editas Medicine Inc haqida